Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer

Clinical Breast Cancer(2023)10.1016/j.clbc.2023.08.002Source: DataRank Database

Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer is a research paper published in Clinical Breast Cancer (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

11 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)OA: closedTopics (24)IDs (PubMed)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Lei Zhang ORCID,Jesus Anampa ORCID,Daniela C. Bravo‐Solarte ORCID

Live enrichment

PubMed:37648557

National Institutes of Health

Grant: 5K12CA132783-08

Paul Calabresi Career Development Award for Clinical Oncology (K12)

National Center for Advancing Translational Sciences

Grant: UL1TR001073

NCI NIH HHS

Grant: K12 CA132783

closedLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S1526820923002094?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1526820923002094?httpAccept=text/plain

https://doi.org/10.1016/j.clbc.2023.08.002

https://pubmed.ncbi.nlm.nih.gov/37648557

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

BreastLymph NodesHumansBreast NeoplasmsNeoplasm StagingChemotherapy, AdjuvantMastectomyFemaleTriple Negative Breast Neoplasms

Keywords

Population-based StudyAdjuvant ChemotherapyBreast Cancer-specific SurvivalOverall-survivalChemotherapy, AdjuvantHumansFemaleTriple Negative Breast NeoplasmsBreast NeoplasmsBreastLymph NodesMastectomyNeoplasm Staging

Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer

FAIR Checklist

Authors (3)

Funding (3 grants)

Open Access

Topics